Although almost the entire world has been sighing under the COVID-19 pandemic since the beginning of March, things are going better than ever in the cannabis industry.
According to a report by the well-known research agency BDSA, global cannabis sales will amount to $19.7 billion (€16.9 billion) this year. That is an increase of no less than 38 percent compared to the previous virus-free year 2019.
Read more about the growing cannabis market and find the most important cannabis news in the world with the Hemp.im mobile app.
Cannabis sales are $4.9 billion more than in 2019
The positive figures for the legal cannabis industry can be found in the most recent market forecast by BDSA, formerly BDS Analytics. This American agency specializes in ‘cannabis market intelligence and consumer research’.
In the year so dominated by the new coronavirus, almost $20 billion worth of cannabis products are sold, and that concerns only the legal sale of medical and recreational cannabis. Last year, a total of $14.8 billion (€12.6 billion) of cannabis products went over the counters of dispensaries and pharmacies.
Furthermore, in the near future, too, the legal cannabis industry looks bright: BDSA predicted that the cannabis market will account for a turnover of $47.2 billion in 2025. That means an annual growth of 22 percent.
The impact of COVID-19 on cannabis sales is very limited
Roy Bingham, co-founder and executive chairman of BDSA, is delighted that the impact of the COVID-19 pandemic has remained very limited for the cannabis industry. Compared to their earlier forecast this year, sales have only been revised downwards by 1%.
“Sales in many U.S. states did better than expected, resulting in positive adjustments for Colorado, Illinois, Michigan, New Mexico, Oklahoma and Oregon. Sales in Nevada (with Las Vegas as metropolis, ed.) fell dramatically and